Managing Primary Immunodeficiency Immunoglobulin Replacement Therapy‐Related Adverse Events With Recombinant Human C1 Esterase Inhibitor Prophylaxis: A Case Report

Documenti analoghi

• Paradoxical Efficacy With Rare Adverse Events: Sequential ALK Inhibitor Therapy in Lung Adenocarcinoma
  di: Kang Xie, et al.
  Pubblicazione: (2026)
• Immunoglobulin G4– Related Disease of the Sternoclavicular Joint: A Case Report
  di: Remi Mizuta, et al.
  Pubblicazione: (2025)
• KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy
  di: Hui Nan, et al.
  Pubblicazione: (2026)
• A Case Report of a Multisystemic Immune‐Related Adverse Event Caused by Sintilimab in Combination With Thymosin Alpha‐1
  di: Ting Li, et al.
  Pubblicazione: (2026)
• Prurigo Nodularis in a Patient With Primary B‐Cell Immunodeficiency Successfully Treated With Low‐Dose Methotrexate: A Case Report
  di: Hamad El Hajj, et al.
  Pubblicazione: (2025)